Acupressure effects on ICU patients' health and well-being
Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence
This study is testing if acupressure can help improve health and well-being for patients in the ICU by looking at things like pain, sleep, and anxiety.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06994715 on ClinicalTrials.gov |
What this trial studies
This study examines the impact of acupressure on patients in the intensive care unit, focusing on physiological parameters, pain, sleep quality, anxiety, and the perception of nursing presence. It employs a randomized controlled design with 60 participants divided into intervention, placebo, and control groups. The intervention group will receive acupressure for two days, while the placebo group will undergo pseudo acupressure, and the control group will receive no treatment. Data will be collected using various assessment tools to evaluate the outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been in intensive care for at least 48 hours and meet specific health criteria.
Not a fit: Patients with psychiatric diagnoses, communication issues, or those receiving certain medications or treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the overall well-being and recovery of ICU patients by reducing anxiety and enhancing sleep quality.
How similar studies have performed: Previous studies have shown promising results with acupressure in various settings, suggesting potential benefits in similar approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have received intensive care treatment for at least 48 hours, * Are 18 years of age or older, * Have a Glasgow Coma Scale score of \>13, * Can speak and write in Turkish, * Have no psychiatric diagnosis, * Have no communication problems, * Have a VAS score of ≥1, * Have a mean arterial pressure of ≥65, * Have SpO2 of ≥85. Exclusion Criteria: Have previously received acupressure treatment, * Have ulcers, necrotic tissue and signs and symptoms of infection at the points where pressure will be applied, * Have used antihypertensives, beta-blockers and similar medications, * Have sedation, * Have respiratory support from the device, * Have inotropic treatment (dopamine, steradin and others), * Have analgesic treatment in their routine treatment will not be included in the study. Patients who were discharged during the study, * Patients who died during the study, * Patients who wanted to leave the study, * Patients who started receiving sedation during the application, * Patients who added antihypertensive, beta-blocker and similar drugs to their routine treatment during the application, * Patients who received inotropic treatment (dopamine, steradin and others) during the application, * Patients who started receiving analgesia treatment during the application, * Patients who developed ulcers, necrotic tissue and infection at the points where pressure will be applied during the application, * Patients who started receiving respiratory support from the device during the application, * Patients who had a Glasgow Coma Scale score of ≤13, mean arterial pressure of ≤65 and SpO2 of ≤85 during the application will be excluded from the study.
Where this trial is running
Ankara
- Ozlem Canbolat — Ankara, Turkey (Recruiting)
Study contacts
- Study coordinator: Ozlem Canbolat
- Email: ozlemcanbolat@gazi.edu.tr
- Phone: +90 312 216 26 86
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.